UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000043212
Receipt No. R000049317
Scientific Title Observational study on thyroid dysfunctions in medullary thyroid carcinoma
Date of disclosure of the study information 2021/02/02
Last modified on 2022/08/04 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Observational study on thyroid dysfunctions in medullary thyroid carcinoma
Acronym Thyroid dysfunctions in medullary thyroid carcinoma
Scientific Title Observational study on thyroid dysfunctions in medullary thyroid carcinoma
Scientific Title:Acronym Thyroid dysfunctions in medullary thyroid carcinoma
Region
Japan

Condition
Condition Medullary thyroid carcinoma
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To clarify the effect of thyroid dysfunctions on the clinical profiles in medullary thyroid cadrcinoma
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Tumor markers on medullary thyroid carcinoma
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria Patients who are diagnosed as medullary thyroid carcinoma
Key exclusion criteria Patients who are not diagnosed as medullary thyroid carcinoma
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Ken
Middle name
Last name Takeshima
Organization Wakayama Medical University
Division name First Department of Internal Medicine
Zip code 641-8509
Address 811-1 Kimi-idera, Wakayama
TEL 0734410625
Email kt10948@wakayama-med.ac.jp

Public contact
Name of contact person
1st name Ken
Middle name
Last name Takeshima
Organization Wakayama Medical University
Division name First Department of Internal Medicine
Zip code 6418509
Address 811-1 Kimi-idera, Wakayama
TEL 0734410625
Homepage URL
Email kt10948@wakayama-med.ac.jp

Sponsor
Institute Wakayama Medical University
Institute
Department

Funding Source
Organization Nothing
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Wakayama Medical University Hospital Ethics Committee
Address 811-1 Kimi-idera, Wakayama
Tel 073-441-0867
Email wa-rinri@wakayama-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 02 Month 02 Day

Related information
URL releasing protocol Nothing
Publication of results Unpublished

Result
URL related to results and publications Nothing
Number of participants that the trial has enrolled 1
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2019 Year 06 Month 03 Day
Date of IRB
2020 Year 06 Month 03 Day
Anticipated trial start date
2020 Year 06 Month 03 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The relationship between thyroid dysfunction and clinical data such as labo data, pathological features, and images.

Management information
Registered date
2021 Year 02 Month 01 Day
Last modified on
2022 Year 08 Month 04 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000049317